Reduced Androgen Receptor Expression in Genital Skin Fibroblasts From Patients With 45,X/46,XY Mosaicism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 14 01 2019
accepted: 03 06 2019
pubmed: 11 6 2019
medline: 9 6 2020
entrez: 11 6 2019
Statut: ppublish

Résumé

Molecular mechanisms causing the broad phenotypic diversity of external masculinization in individuals with 45,X/46,XY mosaicism are poorly understood. Analysis of androgen receptor (AR) expression and function as a putative influencing factor for the genital phenotype in patients with 45,X/46,XY mosaicism. Measurement of AR mRNA expression levels, AR activity [DHT-mediated APOD (apolipoprotein D) induction] and cellular 45,X/46,XY ratios in genital skin fibroblasts from individuals with 45,X/46,XY mosaicism and male reference individuals, and determination of the external virilization scale from individuals with 45,X/46,XY mosaicism. University hospital endocrine research laboratory. Patients or Other Participants: 30 genital skin fibroblast cultures (GFs) from male reference individuals and 15 GFs from individuals with 45,X/46,XY mosaicism. None. Determination of AR mRNA expression and AR activity in male reference GFs and 45,X/46,XY GFs and correlation of the obtained data with the cellular 45,X/46,XY ratios and the patients' external virilization scale. In 6 of 15 45,X/46,XY GFs, AR mRNA expression and AR activity were significantly lower compared with those in the 46,XY reference GFs. In this subgroup of reduced AR mRNA expression, a positive trend was seen between AR mRNA expression and the percentage of XY-positive cells. Furthermore, we found a positive correlation between AR activity and the external virilization scale in the 15 45,X/46,XY GF samples (P = 0.03). Our results suggest that AR expression and AR activity might influence the phenotypic variability seen in patients with 45,X/46,XY mosaicism.

Identifiants

pubmed: 31180485
pii: 5512649
doi: 10.1210/jc.2019-00108
doi:

Substances chimiques

AR protein, human 0
Apolipoproteins D 0
RNA, Messenger 0
Receptors, Androgen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4630-4638

Informations de copyright

Copyright © 2019 Endocrine Society.

Auteurs

Nadine C Hornig (NC)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Jeta Demiri (J)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Pascal Rodens (P)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Eva Maria Murga Penas (EM)

Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Almuth Caliebe (A)

Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Anne Katrin Eckstein (AK)

Gemeinschaftspraxis für Kinderchirurgie, Kronshagen, Germany.

Hans-Udo Schweikert (HU)

Department of Internal Medicine, Division III, University Hospital Bonn, Bonn, Germany.
Institute of Biochemistry and Molecular Biology, University of Bonn, Bonn, Germany.

Laura Audi (L)

Pediatric Endocrinology Research Unit, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Center for Biomedical Network Research on Rare Diseases, Instituto de Salud Carlos III, Barcelona, Spain.

Olaf Hiort (O)

Division of Pediatric Endocrinology, Department of Pediatrics, University Luebeck, Luebeck, Germany.

Ralf Werner (R)

Division of Pediatric Endocrinology, Department of Pediatrics, University Luebeck, Luebeck, Germany.

Alexandra E Kulle (AE)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Ole Ammerpohl (O)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Paul-Martin Holterhus (PM)

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH